Mar 28, 2024, 00:14
E. Anders Kolb: LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group
E. Anders Kolb, President and CEO at The Leukemia and Lymphoma Society, recently posted on LinkedIn:
“As an early funder of research that led to the development of CAR-T cell therapy, The Leukemia & Lymphoma Society has longstanding expertise and commitment to immune-based therapies for treating blood cancers. LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group.”
View additional information.
Source: E. Anders Kolb/LinledIn